Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
32514
CAS Number:
130-95-0
Quinina
Purity:
99 - 101% (Ensayo por titulación)
Documents
$25.20 /5G
Tamaño
Request Bulk Quote
Información del producto

Es útil para tratar la malaria falciparum, el lupus, la artritis y la malaria vivax. Conservar lejos de agentes oxidantes.

Número CAS
130-95-0
Fórmula molecular
C20H24N2O2
Peso molecular
324.42
Número MDL
MFCD00198096
Punto de fusión
174 - 177 °C
Rotación óptica
[a] 20 D = -160 a -170º
Condiciones
Tienda en RT
Información general
Número CAS
130-95-0
Fórmula molecular
C20H24N2O2
Peso molecular
324.42
Número MDL
MFCD00198096
Punto de fusión
174 - 177 °C
Rotación óptica
[a] 20 D = -160 a -170º
Condiciones
Tienda en RT
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Quinine is widely utilized in research focused on

  • Treatment of Malaria: Quinine has been a cornerstone in the treatment of malaria, especially in cases resistant to other medications. Its effectiveness in reducing fever and clearing the parasite from the bloodstream makes it invaluable in tropical medicine.
  • Pharmaceutical Development: Researchers use quinine as a model compound for developing new antimalarial drugs. Its unique chemical structure provides insights into how to enhance efficacy and reduce side effects in new formulations.
  • Flavoring Agent: In the beverage industry, quinine is used to impart a bitter flavor to tonic water and certain cocktails. This application not only enhances taste but also offers a nostalgic touch to classic drinks.
  • Research in Neuroscience: Quinine is studied for its effects on the nervous system, particularly in understanding pain pathways and sensory perception. This research can lead to better pain management therapies.
  • Antioxidant Studies: Quinine has been investigated for its potential antioxidant properties, which may have implications in developing supplements or treatments aimed at oxidative stress-related diseases.

Citas